Navigating tension of clinical equipoise in precision oncology trials

Join us for an expert panel discussion where we will dive into the challenges and opportunities of clinical equipoise in precision oncology trials.

Precision oncology has transformed cancer treatment, offering personalized therapies based on genetic and molecular profiles. However, as the field advances, so do the complexities. The panel will focus on the unique clinical equipoise considerations for pharma and biotech companies. 

Panel Discussion Topics:

• Clinical Equipoise in Precision Oncology Trials: Understand the delicate balance in determining equipoise between standard-of-care treatments and experimental therapies. Learn how to navigate this tension while ensuring patient safety and scientific rigor. 
• Hybrid Trial Designs: Explore innovative trial designs that combine the best of randomized controlled trials (RCTs) and real-world evidence (RWE). Discover how these designs can accelerate drug development and enhance clinical equipoise. 
• Regulatory Insights: Get up-to-date information on regulatory expectations for precision oncology trials. Learn from recent use cases and regulatory decisions and gain practical guidance for successful submissions. 
• Patient-Centric Approaches: Hear patient perspective on control arms in randomized controlled trials and the importance of building trust with patients, which is crucial for advancing precision oncology trials.